Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →

Botanical Drug Safety and Quality Evaluation

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract involves conducting comprehensive analytical and preclinical studies to evaluate the safety, composition, and quality control of botanical drug products. This includes performing toxicology screenings and employing standardization methods to ensure the botanical drugs meet established safety and quality standards. The work is focused on supporting regulatory compliance and scientific validation of these products. Awarded by the FDA Office of Acquisitions and Grants Services under the Department of Health and Human Services, this subcontract falls under the NAICS code 541990, which pertains to specialized scientific services. The principal place of performance is located in Silver Spring, with the contract posted on January 13, 2026. The scope and nature of the contract emphasize the critical role of rigorous quality assessment for botanical drugs, contributing to public health protection and regulatory oversight.

General Info

Conduct comprehensive analytical, toxicology, and quality control studies on botanical drugs for FDA compliance.

Agency

Department Of Health And Human Services → FDA Office Of Acquisitions And Grants ServicesView Agency

NAICS

541990 - All Other Professional, Scientific, and Technical ServicesView NAICS

Place of Performance

Silver Spring, MD, 20993, USA

Set-Aside

NONE

Documents

This scope was carved out of FDABAA-25-00123_Award.

The full solicitation package (2 documents), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

FY25 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → FDA Office Of Acquisitions And Grants Services
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Health And Human Services → FDA Office Of Acquisitions And Grants Services
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Perform analytical and preclinical studies to assess the safety, composition, and quality control of botanical drug products, including toxicology screening and standardization methods.

Similar Contracts

Same NAICS industry code

NAICS: 541990
New
Federal
SAF/CDM Commercial Solutions Opening and Specific Calls
Solicitation # FA7146-21-S-C-0001
The Secretary of the Air Force Concepts Development and Management (SAF/CDM) has issued a Commercial Solutions Opening (CSO) under solicitation number FA7146-21-S-C001 to competitively source innovative commercial technologies and services that address defense-related requirements. This CSO operates on a two-step process that begins with the submission of White Papers, which can be submitted at any time before the deadline on September 1, 2026. Selected White Paper respondents may then be invited to submit full proposals. The initiative supports the Air Force’s goal of closing capability gaps and advancing technological solutions aligned with the mission priorities outlined in the CSO attachment. Multiple awards are anticipated, and the acquisition is open to all vendors, including small businesses, non-traditional contractors, and certain foreign entities. An active call under this CSO is Call A002, focused on Agile Refactoring and Integration for AF/A1, with detailed information and points of contact provided in the call documentation. Awards may be made under either the Federal Acquisition Regulations or Other Transaction Agreement authority, with the government retaining discretion over the extent of any awards. The primary points of contact for this opportunity include Kevin Adams, the Procuring Contracting Officer, and Ms. Catherine Anderson, the Program Manager. Interested parties must follow specific submission guidelines, including email formatting and content requirements, with submissions accepted through September 2026.
FA7146 Saf Oc Pk

POSTED

about 12 hours ago

DEADLINE

in about 2 months
View Details

More opportunities from Department Of Health And Human Services → FDA Office Of Acquisitions And Grants Services

Same awarding agency